January 8, 2026 – National Institutes of Health (NIH) released the following: ...
Update: This story has been corrected to reflect the source of 12-month data for the PRO-Kinetic device. It comes from the previous ENERGY Registry study, and not from the BIOHELIX-1 study. Biotronik ...
In a world-first, a team of researchers at the National Institutes of Health (NIH) and Emory School of Medicine, Atlanta, has successfully performed a coronary artery bypass - a normally open-heart ...
The FDA approved a new emergency stent device to treat perforations in the blood vessels of the heart, the agency’s first new treatment option in the indication in 17 years. Deep tears in coronary ...
Every year, 60,000 people in the UK are diagnosed with heart failure, and many are treated with stents. In a large new study published in the New England Journal of Medicine, my colleagues and I ...
PARIS, France—Two techniques to deal with potential coronary obstruction after TAVI—chimney stenting and the BASILICA procedure—are equally successful when it comes to preventing this rare but ...
PARIS, France—It’s not a stent in a traditional sense, nor a scaffold that completely disappears over time, but a new device—one that “unchains” itself over time—has cleared an early hurdle by proving ...
DUBLIN--(BUSINESS WIRE)--The "Global Coronary Stents Market - Focused Insights 2024-2029" report has been added to ResearchAndMarkets.com's offering. The Global Coronary Stents Market was valued at ...
DEAR DR. ROACH: I am 68 and in good shape; I work out daily. I had a few episodes of angina two to three years ago and started going to a cardiologist as a result. I have had quite a few tests done, ...
Purpose: The mechanism of action and pharmacokinetics of sirolimus when used as part of a drug-eluting stent (DES) and the efficacy and cost of using DESs versus bare-metal stents are discussed.
"There is little doubt that in combination with a controlled drug-eluting design and a reabsorbable polymer, the use of an absorbable stent will likely become a valuable tool in the future." Coronary ...
Results of a large-scale, multicenter study found that treatment with two thin-strut drug-eluting stents were both non-inferior to a durable polymer drug-eluting stent and showed favorable clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results